Hepatic and glucagon-like peptide-1-mediated reversal of diabetes by glucagon receptor antisense oligonucleotide inhibitors.
Sloop KW, Cao JX, Siesky AM, Zhang HY, Bodenmiller DM, Cox AL, Jacobs SJ, Moyers JS, Owens RA, Showalter AD, Brenner MB, Raap A, Gromada J, Berridge BR, Monteith DK, Porksen N, McKay RA, Monia BP, Bhanot S, Watts LM, Michael MD.
Sloop KW, et al. Among authors: bhanot s.
J Clin Invest. 2004 Jun;113(11):1571-81. doi: 10.1172/JCI20911.
J Clin Invest. 2004.
PMID: 15173883
Free PMC article.